A 20-Year Follow-Up of a Population Study-Based COPD Cohort-Report from the Obstructive Lung Disease in Northern Sweden Studies

REFERENCES

• Incalzi R A, Fuso L, De Rosa M, Forastiere F, Rapiti E B, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2794–2800
   PubMed Web of Science ®Google Scholar
• Martinez F J, Foster G, Curtis J L, Criner G, Weinmann G, Fishman A, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173: 1326–1334
   PubMed Web of Science ®Google Scholar
• Soriano J B, Vestbo J, Pride N B, Kiri V, Maden C, Maier W C. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002; 20: 819–825
   PubMed Web of Science ®Google Scholar
• Mannino D M, Gagnon R C, Petty T L, Lydick E. Obstructive lung disease and low lung function in adults in the United States. Data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2000; 160: 1683–1689
   PubMed Web of Science ®Google Scholar
• Soriano J B, Maier W C, Egger P, Visik G, Thakrar B, Sykes J, Pride N B. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55: 789–795
   PubMed Web of Science ®Google Scholar
• Lundbäck B, Jönsson E, Jonsson A-C, Rönmark E, Lindström M, Lindberg A, et al. Not fifteen but fifty percent of smokers develop COPD—report from the Obstructive Lung Disease Studies in Northern Sweden. Respir Med 2003; 97: 115–122
   PubMed Web of Science ®Google Scholar
• Mannino D M, Brown C, Giovino G A. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997; 156: 814–818
   PubMed Web of Science ®Google Scholar
• Halpin D. Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena. COPD 2008; 5: 187–200
   PubMedGoogle Scholar
• Schunemann H J, Dorn J, Grant B, Winklestein W, Trevisan M. Pulmonary function is a long term predictor of mortality in the general påopulation. 29-year follow-up of the Buffalo Health Study. Chest 2000; 118: 656–664
   PubMed Web of Science ®Google Scholar
• Mannino D M, Buist A S, Petty T L, Enright P L, Redd S C. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003; 58: 388–393
   PubMed Web of Science ®Google Scholar
• Lökke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61: 935–939
   PubMed Web of Science ®Google Scholar
• Mannino D M, Davis K J. Lung function decline and outcomes in an elderly population. Thorax 2006; 61: 472–477
   PubMed Web of Science ®Google Scholar
• Lundbäck B, Nyström L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal review. Eur Respir J 1991; 4: 257–266
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152(S)77–120
   Google Scholar
• Siafakas N M, Vermeire P, Pride N B, Paoletti P, Gibson J, Howard P. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 398–420
   PubMedGoogle Scholar
• British Thoracic Society. BTS Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52(S5)1–28
   PubMedGoogle Scholar
• Lindberg A, Bjerg-Bäcklund A, Rönmark E, Larsson L G, Lundbäck B. Prevalence and under diagnosis of COPD by disease severity and the attributable fraction of smoking – Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006; 100(2)264–272
   PubMed Web of Science ®Google Scholar
• Lindberg A, Jonsson A-C, Rönmark E, Lundgren R, Larsson L-G, Lundbäck B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005; 127: 1544–1552
   PubMed Web of Science ®Google Scholar
• Lindberg A, Eriksson B, Larsson L G, Rönmark E, Sandström T, Lundbäck B. 7-year cumulative incidence of COPD in an age-stratified general population sample. Chest 2006; 129: 879–885
   PubMed Web of Science ®Google Scholar
• Jansson S-A, Lindberg A, Ericsson Å, Borg S, Rönmark E, Andersson F, Lundbäck B. Cost differences for COPD with and without physician-diagnosis. COPD 2005; 3: 427–434
   Google Scholar
• Rabe K F, Hurd S, Anzueto A, Barnes P J, Buist S A, Calverley P, Fukuchi Y, Jenkins C, Rodriquez-Roisin R, van Weel C, Zielinski J. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. GOLD Executive Summary. Am J Respir Crit Care Med 2007; 176: 532–555
   PubMed Web of Science ®Google Scholar
• Celli B, MacNee W, committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932–946
   PubMed Web of Science ®Google Scholar
• Lundbäck B, Stjernberg N, Nyström L, Forsberg B, Lindström M, Lundbäck K, et al. Epidemiology of respiratory symptoms, lung function and important determinants. Report from the Northern Sweden Obstructive Lung Disease Project. Tuber Lung Dis 1994; 75: 116–126
   PubMedGoogle Scholar
• Lindberg A, Larsson L-G, Rönmark E, Jonsson A-C, Larsson K, Lundbäck B. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. COPD 2007; 4: 5–13
   PubMedGoogle Scholar
• Rönmark E, Lundbäck B, Jönsson E, Jonsson A-C, Lindström M, Sandström T. Incidence of asthma in adults—report from the Obstructive Lung Disease in Northern Sweden study. Allergy 1997; 52: 1071–1078
   PubMed Web of Science ®Google Scholar
• Rönmark E, Jönsson E, Lundbäck B. Remission of asthma in middle-aged and elderly - report from the Obstructive Lung Disease in Northern Sweden Study. Thorax 1999; 54: 611–613
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Snowbird workshop on standardization of spirometry. Am Rev Respir Dis 1979; 119: 831–838
   PubMed Web of Science ®Google Scholar
• Berglund E, Birath G, Grimby G. Spirometric studies in normal subjects, forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 1963; 173: 185–192
   PubMed Web of Science ®Google Scholar
• Pallasaho P, Lundbäck B, Läspä S-L, Jönsson E, Sovijärvi A, Laitinen L. Increasing prevalence of asthma but not chronic bronchitis in Finland—Report from the FinEsS-Helsinki study. Respir Med 1999; 93: 798–809
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña J J, Martínez-García M A, Sánchez P R, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925–931
   PubMed Web of Science ®Google Scholar
• Statistics Sweden, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005. Causes of death, www.scb.se
   Google Scholar
• Fuhrman C, Jougla E, Nicolau D, Eilstein D, Delmas M C. Deaths from chronic obstructive pulmonary disease in France, 1979–2002: a multiple cause analysis. Thorax 2006; 61: 930–934
   PubMed Web of Science ®Google Scholar
• Hansell A L, Walk J A, Soriano J B. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22: 809–814
   PubMed Web of Science ®Google Scholar
• Mannino D M, Homa D M, Akinbami L J, Ford E S, Redd S C. Chronic obstructive pulmonary disease surveillance – United States, 1971–2000. Respir Care 2002; 47: 1184–1199
   PubMedGoogle Scholar
• Stang P, Lydick E, Silberman C, Kempel A, Keating E. The prevalence of COPD. Using smoking rates to estimate disease frequency in the general population. Chest 2000; 117(S)354–359
   PubMedGoogle Scholar
• Calverley P M, Anderson J A, Celli B, Ferguson G T, Jenkins C, TORCH investigators, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 777–789
   Google Scholar
• Bale G, Martinez-Camblor P, Burge P S, Soriano J B. Long-term mortality follow-up of the ISOLDE participants: Causes of death during 13 years after trial completion. Respir Med 2008; 102: 1468–1472
   PubMed Web of Science ®Google Scholar
• Anthonisen N R, Skeans M A, Wise R A, Manfreda J, Kanner R E, Connett J E. The effects of a smoking cessation intervention on 14.5-year mortality. A Randomized Clinical Trial. Ann Intern Med 2005; 142: 233–239
   PubMed Web of Science ®Google Scholar
• Kauffmann F, Annesi I, Chwalow J. Validity of subjective assessment of changes in respiratory health status: a 30 year epidemiological study of workers in Paris. Eur Respir J 1997; 10: 2508–2514
   PubMed Web of Science ®Google Scholar
• Bakke P S, Hanoa R, Gulsvik A. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study. Am J Epidemiol 1995; 141: 1080–1088
   PubMed Web of Science ®Google Scholar
• Bergdahl I A, Torén K, Eriksson K, Hedlund U, Nilsson T, Flodin R, Järvholm B. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J 2004; 23: 402–406
   PubMed Web of Science ®Google Scholar
• Pope C A, Ezzati M, Dockery D W. Fine-particulate air pollution and life expectancy in the United States. N Engl J Med 2009; 360: 376–386
   PubMed Web of Science ®Google Scholar
• Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640–2646
   PubMed Web of Science ®Google Scholar
• Ekberg-Aronsson M, Pehrsson K, Nilsson JÅ, Nilsson P M, Löfdahl C G. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6: 98, doi:10.1186/1465-9921-6-98
   PubMed Web of Science ®Google Scholar
• Kotaniemi J T, Sovijärvi A, Lundbäck B. Chronic Obstructive Pulmonary Disease in Finland: Prevalence and risk factors. COPD 2005; 3: 331–339
   Google Scholar